CHERI SLINGWINE: Open Payments
NPI 1881340966 · SANDUSKY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,498 in 84 payments from 21 companies in 2025. Trend: 2023 $576 · 2024 $658 · 2025 $1,498
Food & beverage: $1,386Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 12 | $274 |
| ABBVIE INC. | 23 | $268 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $175 |
| Alkermes, Inc. | 10 | $151 |
| E.R. Squibb & Sons, L.L.C. | 5 | $83 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Vanda Pharmaceuticals Inc. | 3 | $75 |
| Braeburn Inc. | 3 | $58 |
| Lundbeck LLC | 2 | $47 |
| Axsome Therapeutics, Inc. | 2 | $40 |
Products named: VRAYLAR, CAPLYTA, ARISTADA, AUSTEDO XR, COBENFY, REXULTI, FANAPT, BRIXADI.
Industry payments across OH — which companies pay providers there.
